Massachusetts Wants To Rein In Drug Prices By Limiting What Medications Are Covered By Medicaid

But advocates and drug companies say that would harm patients and be a radical departure from how Medicaid operates now. The decision could have a nationwide impact as states look at ways to bring down spiking drug costs. Meanwhile, a new study supports the industry's argument that even as list prices rise, net prices are going down with discounts like rebates.

from Kaiser Health News https://ift.tt/2GPeUqc